Renaissance Technologies’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,074,900
Closed -$21.8M 4328
2021
Q3
$21.8M Buy
1,074,900
+327,700
+44% +$8.42M 0.03% 636
2021
Q2
$24.7M Buy
747,200
+203,000
+37% +$7.66M 0.03% 628
2021
Q1
$21.3M Buy
+544,200
New +$25.6M 0.03% 738
2020
Q4
Sell
-239,200
Closed -$6.78M 3823
2020
Q3
$6.78M Sell
239,200
-183,400
-43% -$5.79M 0.01% 1389
2020
Q2
$15.3M Buy
+422,600
New +$11.9M 0.01% 970

Other funds holding ONEM

Renaissance Technologies's ONEM Position: Q4 2021 in Review

Renaissance Technologies sold out of 1Life Healthcare (ONEM) in Q4 2021, closing a stake of 1,074,900 shares — an estimated $21.8M sold.

Renaissance Technologies first reported a position in ONEM in Q2 2020 and held it in 5 quarters. The position peaked at $24.7M in Q2 2021. 201 funds tracked by Wall St. Rank hold ONEM as of Q4 2021.

  • Renaissance Technologies reported no remaining 1Life Healthcare position as of Q4 2021 after selling out during the quarter.
  • Renaissance Technologies sold 1,074,900 1Life Healthcare shares in Q4 2021, an estimated $21.8M.
  • Renaissance Technologies first reported a position in 1Life Healthcare in Q2 2020 and held it in 5 quarters.
  • Renaissance Technologies's 1Life Healthcare position peaked at $24.7M in Q2 2021.
  • 201 funds tracked by Wall St. Rank held 1Life Healthcare as of Q4 2021.

Based on Renaissance Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.